Non-trisomic homeobox gene expression during craniofacial development in the Ts65Dn mouse model of Down syndrome

American Journal of Medical Genetics, Part A

Volumn 161, Issue 8, 2013, Pages 1866-1874

  Billingsley, Cherie N ^a   Allen, Jared R ^a   Baumann, Douglas D ^b   Deitz, Samantha L ^a   Blazek, Joshua D ^a   Newbauer, Abby ^a   Darrah, Andrew ^a   Long, Brad C ^c   Young, Brandon ^c   Clement, Mark ^d   Doerge, R W ^b   Roper, Randall J ^a  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b PURDUE UNIVERSITY   (United States)

^c Genomics Core   (United States)

^d 3361 TMCB   (United States)

Author keywords

Developmental delay disorders; Experimental animal models; Genotype phenotype correlation; Trisomy 21

Indexed keywords

DNA BINDING PROTEIN; HOMEODOMAIN PROTEIN; TRANSCRIPTION FACTOR OTX2; TRANSCRIPTION FACTOR SOX9;

ADAMTS1 GENE; ANEUPLOIDY; ANIMAL EXPERIMENT; ANIMAL MODEL; APP GENE; ARTICLE; ATP5O GENE; BRAIN; CBR3 GENE; CELL PROLIFERATION; CLIC6 GENE; CONTROLLED STUDY; CRANIOFACIAL DEVELOPMENT; CRANIOFACIAL MALFORMATION; DEVELOPMENTAL DISORDER; DOWN SYNDROME; DYRK1A GENE; EMBRYO; ERG GENE; GABPA GENE; GENE EXPRESSION; GENE INTERACTION; GENOTYPE PHENOTYPE CORRELATION; GESTATIONAL AGE; GRIK1 GENE; HEART; HMGN1 GENE; HUNK GENE; HYOID BONE; IFNAR1 GENE; IFNAR2 GENE; ITSN1 GENE; KCNE2 GENE; LIVER; MANDIBLE; MECKEL DIVERTICULUM; MICROARRAY ANALYSIS; MOUSE; MRPS6 GENE; MX1 GENE; NEOCORTEX; NONHUMAN; OLIG2 GENE; PHENOTYPE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DOMAIN; QUANTITATIVE ANALYSIS; RCAN1 GENE; RIPK4 GENE; RNA ISOLATION; RUNX1 GENE; TIAM1 GENE; TONGUE; TRISOMY 21; UPREGULATION;

DEVELOPMENTAL DELAY DISORDERS; EXPERIMENTAL ANIMAL MODELS; GENOTYPE-PHENOTYPE CORRELATION; TRISOMY 21;

ANIMALS; BIOLOGICAL MARKERS; CELL PROLIFERATION; CRANIOFACIAL ABNORMALITIES; DISEASE MODELS, ANIMAL; DOWN SYNDROME; EMBRYO, MAMMALIAN; FEMALE; GENE EXPRESSION PROFILING; MANDIBLE; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHENOTYPE; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SOX9 TRANSCRIPTION FACTOR; TRISOMY;

ANIMALIA; MUS;

EID: 84880755185     PISSN: 15524825     EISSN: 15524833     Source Type: Journal    
DOI: 10.1002/ajmg.a.36006     Document Type: Article

References (54)

1. Ait Yahya-Graison E, Aubert J, Dauphinot L, Rivals I, Prieur M, Golfier G, Rossier J, Personnaz L, Creau N, Blehaut H, Robin S, Delabar JM, Potier MC. 2007. Classification of human chromosome 21 gene-expression variations in Down syndrome: Impact on disease phenotypes. Am J Hum Genet 81:475-491.
2. Akiyama H, Lyons JP, Mori-Akiyama Y, Yang X, Zhang R, Zhang Z, Deng JM, Taketo MM, Nakamura T, Behringer RR, McCrea PD, de Crombrugghe B. 2004. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev 18:1072-1087.
3. Allanson JE, O'Hara P, Farkas LG, Nair RC. 1993. Anthropometric craniofacial pattern profiles in Down syndrome. Am J Med Genet 47:748-752.
4. Arron JR, Winslow MM, Polleri A, Chang CP, Wu H, Gao X, Neilson JR, Chen L, Heit JJ, Kim SK, Yamasaki N, Miyakawa T, Francke U, Graef IA, Crabtree GR. 2006. NFAT dysregulation by increased dosage of DSCR1 and DYRK1A on chromosome 21. Nature 441:595-600.
5. Barrow JR, Capecchi MR. 1996. Targeted disruption of the Hoxb-2 locus in mice interferes with expression of Hoxb-1 and Hoxb-4. Development 122:3817-3828.
6. Baxter LL, Moran TH, Richtsmeier JT, Troncoso J, Reeves RH. 2000. Discovery and genetic localization of Down syndrome cerebellar phenotypes using the Ts65Dn mouse. Hum Mol Genet 9:195-202.
7. Belichenko PV, Masliah E, Kleschevnikov AM, Villar AJ, Epstein CJ, Salehi A, Mobley WC. 2004. Synaptic structural abnormalities in the Ts65Dn mouse model of Down syndrome. J Comp Neurol 480:281-298.
8. Benjamini Y, Hochberg Y. 1995. Controlling for false discovery rate: A practical and powerful approach to multiple testing. J R Stat Soc Ser B 57:289-300.
9. Blazek JD, Billingsley CN, Newbauer A, Roper RJ. 2010. Embryonic and not maternal trisomy causes developmental attenuation in the Ts65Dn mouse model for Down syndrome. Dev Dyn 239:1645-1653.
10. Chakrabarti L, Galdzicki Z, Haydar TF. 2007. Defects in embryonic neurogenesis and initial synapse formation in the forebrain of the Ts65Dn mouse model of Down syndrome. J Neurosci 27:11483-11495.
11. Chen H, Zhang H, Lee J, Liang X, Wu X, Zhu T, Lo PK, Zhang X, Sukumar S. 2007. HOXA5 acts directly downstream of retinoic acid receptor beta and contributes to retinoic acid-induced apoptosis and growth inhibition. Cancer Res 67:8007-8013.
12. Clement K, Gustafson N, Berbert A, Carroll H, Merris C, Olsen A, Clement M, Snell Q, Allen J, Roper RJ. 2010. PathGen: A transitive gene pathway generator. Bioinformatics 26:423-425.
13. Dauphinot L, Lyle R, Rivals I, Dang MT, Moldrich RX, Golfier G, Ettwiller L, Toyama K, Rossier J, Personnaz L, Antonarakis SE, Epstein CJ, Sinet PM, Potier MC. 2005. The cerebellar transcriptome during postnatal development of the Ts1Cje mouse, a segmental trisomy model for Down syndrome. Hum Mol Genet 14:373-384.
14. Deckelbaum RA, Majithia A, Booker T, Henderson JE, Loomis CA. 2006. The homeoprotein engrailed 1 has pleiotropic functions in calvarial intramembranous bone formation and remodeling. Development 133:63-74.
15. Degenhardt K, Rentschler S, Fishman G, Sassoon DA. 2002. Cellular and cis-regulation of En-2 expression in the mandibular arch. Mech Dev 111:125-136.
16. Deitz SL, Roper RJ. 2011. Trisomic and allelic differences influence phenotypic variability during development of Down syndrome mice. Genetics 189:1487-1495.
17. Dennis G Jr, Sherman BT, Hosack DA, Yang J, Gao W, Lane HC, Lempicki RA. 2003. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol 4:P3.
18. Epstein CJ. 2001. Down syndrome (trisomy 21). In: Scriver CR, Beaudet AL, Sly WS, Valle D, editors. The metabolic and molecular bases of inherited disease. New York: McGraw-Hill. pp 1223-1256.
19. Faulks D, Collado V, Mazille MN, Veyrune JL, Hennequin M. 2008. Masticatory dysfunction in persons with Down's syndrome. Part 1: Aetiology and incidence. J Oral Rehabil 35:854-862.
20. Guihard-Costa AM, Khung S, Delbecque K, Menez F, Delezoide AL. 2006. Biometry of face and brain in fetuses with trisomy 21. Pediatr Res 59:33-38.
21. Guimaraes CV, Donnelly LF, Shott SR, Amin RS, Kalra M. 2008. Relative rather than absolute macroglossia in patients with Down syndrome: Implications for treatment of obstructive sleep apnea. Pediatr Radiol 38:1062-1067.
22. Hewitt CA, Carmichael CL, Wilkins EJ, Cannon PZ, Pritchard MA, Scott HS. 2007. Multiplex ligation-dependent probe amplification (MLPA) genotyping assay for mouse models of Down syndrome. Front Biosci 12:3010-3016.
23. Hill CA, Reeves RH, Richtsmeier JT. 2007. Effects of aneuploidy on skull growth in a mouse model of Down syndrome. J Anat 210:394-405.
24. Holm S. 1979. A simple sequentially rejective multiple test procedure. Scand J Stat 6:65-70.
25. Huang da W, Sherman BT, Lempicki RA. 2009. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc 4:44-57.
26. Kaur S, Singh G, Stock JL, Schreiner CM, Kier AB, Yager KL, Mucenski ML, Scott WJ Jr, Potter SS. 1992. Dominant mutation of the murine Hox-2.2 gene results in developmental abnormalities. J Exp Zool 264:323-336.
27. Kimura C, Takeda N, Suzuki M, Oshimura M, Aizawa S, Matsuo I. 1997. Cis-acting elements conserved between mouse and pufferfish Otx2 genes govern the expression in mesencephalic neural crest cells. Development 124:3929-3941.
28. Kirkeby S, Thomsen CE. 2005. Quantitative immunohistochemistry of fluorescence labelled probes using low-cost software. J Immunol Methods 301:102-113.
29. Knight RD, Schilling TF. 2006. Cranial neural crest and development of the head skeleton. Adv Exp Med Biol 589:120-133.
30. Laffaire J, Rivals I, Dauphinot L, Pasteau F, Wehrle R, Larrat B, Vitalis T, Moldrich RX, Rossier J, Sinkus R, Herault Y, Dusart I, Potier MC. 2009. Gene expression signature of cerebellar hypoplasia in a mouse model of Down syndrome during postnatal development. BMC Genomics 10:138.
31. Lana-Elola E, Watson-Scales SD, Fisher EM, Tybulewicz VL. 2011. Down syndrome: Searching for the genetic culprits. Dis Model Mech 4:586-595.
32. Liu C, Morishima M, Yu T, Matsui S, Zhang L, Fu D, Pao A, Costa AC, Gardiner KJ, Cowell JK, Nowak NJ, Parmacek MS, Liang P, Baldini A, Yu YE. 2011. Genetic analysis of Down syndrome-associated heart defects in mice. Hum Genet 130:623-632.
33. Matkowskyj KA, Schonfeld D, Benya RV. 2000. Quantitative immunohistochemistry by measuring cumulative signal strength using commercially available software photoshop and matlab. J Histochem Cytochem 48:303-312.
34. Matsuo I, Kuratani S, Kimura C, Takeda N, Aizawa S. 1995. Mouse Otx2 functions in the formation and patterning of rostral head. Genes Dev 9:2646-2658.
35. Mori-Akiyama Y, Akiyama H, Rowitch DH, de Crombrugghe B. 2003. Sox9 is required for determination of the chondrogenic cell lineage in the cranial neural crest. Proc Natl Acad Sci USA 100:9360-9365.
36. Mouton PR. 2002. Principles and practices of unbiased stereology: An introduction for bioscientists. Baltimore: Johns Hopkins University Press.
37. Parker SE, Mai CT, Canfield MA, Rickard R, Wang Y, Meyer RE, Anderson P, Mason CA, Collins JS, Kirby RS, Correa A. 2010. Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res A Clin Mol Teratol 88:1008-1016.
38. Ramaesh T, Bard JB. 2003. The growth and morphogenesis of the early mouse mandible: A quantitative analysis. J Anat 203:213-222.
39. Reeves RH, Irving NG, Moran TH, Wohn A, Kitt C, Sisodia SS, Schmidt C, Bronson RT, Davisson MT. 1995. A mouse model for Down syndrome exhibits learning and behaviour deficits. Nat Genet 11:177-184.
40. Richtsmeier JT, Baxter LL, Reeves RH. 2000. Parallels of craniofacial maldevelopment in Down syndrome and Ts65Dn mice. Dev Dyn 217:137-145.
41. Roper RJ, Baxter LL, Saran NG, Klinedinst DK, Beachy PA, Reeves RH. 2006a. Defective cerebellar response to mitogenic Hedgehog signaling in Down [corrected] syndrome mice. Proc Natl Acad Sci USA 103:1452-1456.
42. Roper RJ, St John HK, Philip J, Lawler A, Reeves RH. 2006b. Perinatal loss of Ts65Dn Down syndrome mice. Genetics 172:437-443.
43. Roper RJ, VanHorn JF, Cain CC, Reeves RH. 2009. A neural crest deficit in Down syndrome mice is associated with deficient mitotic response to Sonic hedgehog. Mech Dev 126:212-219.
44. Rozovski U, Jonish-Grossman A, Bar-Shira A, Ochshorn Y, Goldstein M, Yaron Y. 2007. Genome-wide expression analysis of cultured trophoblast with trisomy 21 karyotype. Hum Reprod 22:2538-2545.
45. Santagati F, Rijli FM. 2003. Cranial neural crest and the building of the vertebrate head. Nat Rev Neurosci 4:806-818.
46. Santagati F, Minoux M, Ren SY, Rijli FM. 2005. Temporal requirement of Hoxa2 in cranial neural crest skeletal morphogenesis. Development 132:4927-4936.
47. Saran NG, Pletcher MT, Natale JE, Cheng Y, Reeves RH. 2003. Global disruption of the cerebellar transcriptome in a Down syndrome mouse model. Hum Mol Genet 12:2013-2019.
48. Shott SR. 2006. Down syndrome: Common otolaryngologic manifestations. Am J Med Genet Part C Semin Med Genet 142C:131-140.
49. Sommer CA, Pavarino-Bertelli EC, Goloni-Bertollo EM, Henrique-Silva F. 2008. Identification of dysregulated genes in lymphocytes from children with Down syndrome. Genome 51:19-29.
50. Sturgeon X, Gardiner KJ. 2011. Transcript catalogs of human chromosome 21 and orthologous chimpanzee and mouse regions. Mamm Genome 22:261-271.
51. Williams AD, Mjaatvedt CH, Moore CS. 2008. Characterization of the cardiac phenotype in neonatal Ts65Dn mice. Dev Dyn 237:426-435.
52. Wiseman FK, Alford KA, Tybulewicz VL, Fisher EM. 2009. Down syndrome-Recent progress and future prospects. Hum Mol Genet 18:R75-R83.
53. Zhai J, Lin H, Canete-Soler R, Schlaepfer WW. 2005. HoxB2 binds mutant SOD1 and is altered in transgenic model of ALS. Hum Mol Genet 14:2629-2640.
54. Zhong SC, Chen XS, Cai QY, Luo X, Chen XH, Liu J, Yao ZX. 2010. Dynamic expression and heterogeneous intracellular location of En-1 during late mouse embryonic development. Cells Tissues Organs 191:289-300.